Clinical Trials for Neuroendocrine Tumors

Find clinical trials for neuroendocrine tumors. Discover research opportunities and treatment options in your area.

88 Active Trials Found

Showing 88 trials on this page

Page 2 of 5

Iconographic Registry of Pancreatobiliary Endoscopy Procedures

NCT ID: NCT06344507

The TAILOR-EUS study is a clinical trial focused on collecting images and videos from endoscopic procedures used to investigate various pancreatic diseases, such as pancreatitis (inflammation of th...

Recruiting

Type: observational Locations: Milan, , Italy

SVV-001 With Nivolumab and Ipilimumab in Patients With Poorly Differentiated Neuroendocrine Carcinomas (NEC) or Well-Differentiated High-Grade Neuroendocrine Tumors (NET)

NCT ID: NCT06889493

This clinical trial is exploring a new treatment option for patients with advanced neuroendocrine tumors (NET) or poorly differentiated neuroendocrine carcinomas (NEC). Specifically, the study aims...

Recruiting

Phase: PHASE1 Type: interventional Locations: Miami, Florida, United States

A Phase 1/2 Study to Evaluate CHM-2101, an Autologous Cadherin 17 Chimeric Antigen Receptor (CAR) T Cell Therapy

NCT ID: NCT06055439

This clinical trial is testing a new treatment called CHM-2101, which is a type of CAR T-cell therapy designed to help patients with certain advanced gastrointestinal cancers, like colorectal and g...

Recruiting

Phase: PHASE1 Type: interventional Locations: Philadelphia, Pennsylvania, United States, Chicago, Illinois, United States +3 more

18F Labeled FAP Targeted Molecular Probe in Early Tumor Diagnosis

NCT ID: NCT06937112

This clinical trial is studying a new imaging tool called 18F-FAPI-YQ104, which helps doctors see and diagnose certain types of tumors, including lung, pancreatic, thyroid cancers, and neuroendocri...

Recruiting

Type: observational Locations: Nanjing, Jiangsu, China

Cessation of Somatostatin Analogues After PRRT in Mid, Hind-Gut and Pancreatic Neuroendocrine Tumours

NCT ID: NCT06345079

This clinical trial is studying the effects of stopping or continuing a type of treatment called somatostatin analogues (SSA) after patients receive another treatment known as Peptide Receptor Radi...

Recruiting

Phase: PHASE2 Type: interventional Locations: Regina, Saskatchewan, Canada, Sydney, New South Wales, Australia +7 more

Rediscovering Biomarkers for the Diagnosis and Early Treatment Response in NEN (REBORN)

NCT ID: NCT04464122

The REBORN trial is a study looking at new ways to diagnose and monitor the treatment of neuroendocrine tumors (NENs), which are a type of cancer that can arise from hormone-producing cells. Resear...

Recruiting

Type: observational Locations: Rome, , Italy

Comparison of Al18F-NOTA-LM3 With 68Ga-DOTATATE and 68Ga-NODAGA-LM3 PET/CT in Patients With Well-differentiated Neuroendocrine Tumors

NCT ID: NCT06056362

This clinical trial is studying a new imaging agent called Al18F-NOTA-LM3 to see how well it helps doctors find and diagnose well-differentiated neuroendocrine tumors (NETs). The researchers want t...

Recruiting

Phase: PHASE1 Type: interventional Locations: Beijing, , China

Gene Modified Immune Cells (IL13Ralpha2 CAR T Cells) After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors

NCT ID: NCT04119024

This clinical trial is testing a new treatment for patients with advanced melanoma and other types of solid tumors that have spread in the body. The treatment involves using specially modified immu...

Recruiting

Phase: PHASE1 Type: interventional Locations: Duarte, California, United States, Los Angeles, California, United States +1 more

TARGETed Therapy Drug MONITOring in DIGestive Oncology

NCT ID: NCT05443087

The TARGETed Therapy Drug MONITOring in DIGestive Oncology trial is researching how to better manage and adjust doses of specific cancer medications for patients with advanced digestive cancers, su...

Recruiting

Phase: NA Type: interventional Locations: Lille, , France, Nice, , France +31 more

The Australia and New Zealand Multicentre Upper Gastrointestinal Endoscopic Tissue Resection Study

NCT ID: NCT05804331

This clinical trial, called the Australia and New Zealand Multicentre Upper Gastrointestinal Endoscopic Tissue Resection Study, is looking at the long-term effects of different procedures used to r...

Recruiting

Type: observational Locations: Sydney, New South Wales, Australia

Natural History and Management of Von Hippel-Lindau (VHL) Associated Pancreatic Neuroendocrine Tumors

NCT ID: NCT04074135

This clinical trial is studying how von Hippel-Lindau (VHL) disease affects the pancreas, particularly looking at tumors that can form there. The researchers want to see if a special type of scan, ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Bethesda, Maryland, United States

Antibody Drug Conjugate ADCT-701 in Neuroendocrine Tumors and Carcinomas

NCT ID: NCT06041516

This clinical trial is studying a new treatment called ADCT-701 for patients with neuroendocrine tumors and carcinomas, which are rare types of cancer found in places like the gastrointestinal trac...

Recruiting

Phase: PHASE1 Type: interventional Locations: Bethesda, Maryland, United States

Tissue Procurement and Natural History Study of Neuroendocrine Neoplasms (NENs) Including Adrenocortical Carcinoma (ACC)

NCT ID: NCT05237934

This clinical trial is focused on understanding neuroendocrine neoplasms (NENs), which are rare types of cancers that can develop in various parts of the body, including the pancreas, lungs, and ad...

Recruiting

Type: observational Locations: Bethesda, Maryland, United States

Absorbed Tumor Dose in Peptide Receptor Radionuclide Therapy with Long-acting Somatostatin Analogues - ATSA Trial

NCT ID: NCT06855095

The ATSA Trial is a clinical study looking at how a specific treatment, called Peptide Receptor Radionuclide Therapy (PRRT), works for patients with neuroendocrine tumors, which are a type of cance...

Recruiting

Phase: PHASE2 Type: interventional Locations: Amsterdam, , Netherlands

F-Tryptophan PET/CT in Human Cancers

NCT ID: NCT05556473

This clinical trial, titled "F-Tryptophan PET/CT in Human Cancers," is studying a new imaging method that may help doctors better understand how well certain cancers are responding to treatment. Th...

Recruiting

Phase: PHASE1 Type: interventional Locations: Detroit, Michigan, United States

Study of the Value of HPG80 (circulating Progastrin) for the Diagnosis of Neuroendocrine Tumours in Patients with an MEN1 Mutation

NCT ID: NCT06430021

This clinical trial is studying a new blood test called hPG80 to see if it can help diagnose neuroendocrine tumors (NETs) in patients who have a genetic condition known as Multiple Endocrine Neopla...

Recruiting

Type: observational Locations: Dijon, , France, Dijon, Côte D'or, France

PARP Inhibitor With 177Lu-DOTA-Octreotate PRRT in Patients With Neuroendocrine Tumours

NCT ID: NCT05053854

This clinical trial is exploring a new treatment approach for patients with advanced neuroendocrine tumors, particularly those originating from the pancreas or intestines. The study is looking at a...

Recruiting

Phase: PHASE1 Type: interventional Locations: Melbourne, , Australia, Melbourne, Victoria, Australia

Clinical Application of the J-PET Scanner Prototype

NCT ID: NCT06242119

This clinical trial is exploring a new type of imaging technology called the J-PET scanner, which is designed to help doctors better diagnose certain conditions like prostate cancer and other relat...

Recruiting

Type: observational Locations: Krakow, , Poland

A Phase I Study to Assess the Safety and Efficacy of [225Ac]Ac-DOTATATE in Patients with SSTR+ GEP-Nets

NCT ID: NCT06732505

This clinical trial is studying a new treatment called [225Ac]Ac-DOTATATE for patients with a type of cancer known as gastroenteropancreatic neuroendocrine tumors (GEP-NETs). Specifically, it is lo...

Recruiting

Phase: PHASE1 Type: interventional Locations: Beijing, Beijing, China

Clinico-biological Database in Patients Treated With Metabolic Radiotherapy in the Nuclear Medicine Department

NCT ID: NCT04104529

This clinical trial is focused on creating a special database that collects important clinical and biological information from patients being treated with metabolic radiotherapy for certain types o...

Recruiting

Phase: NA Type: interventional Locations: Montpellier, , France, Bordeaux, Aquitaine, France +3 more

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions